Clinical Trial Update: Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial (Stereosarc) is evaluating stereotaxic body irradiation for oligometastases in sarcoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Sarcoma, Radiosurgery | Phase 2 | Status: RECRUITING